Pernod's China-US Collapse Signals Consumer Spending Has Turned Structural

When a €9.4 billion global spirits manufacturer can't move premium alcohol in America and China simultaneously, you are not looking at a cyclical downturn. You are looking at a structural deterioration in consumer demand that transcends geography, brand equity, and price point. Pernod Ricard's third consecutive year of sales decline—and the grim timeline it just announced—should worry anyone still betting on a near-term consumer recovery.

The numbers landed Thursday with the weight of a missed call. Pernod's organic sales fell 3.9% in fiscal 2026, worse than the 3.7% contraction analysts had priced in. The US market contracted 14%. China contracted 19%. These are not modest pullbacks. These are the kinds of declines you see when structural demand has left the building.

What makes this genuinely important is not the headline miss—those happen quarterly—but the forecast. CEO Alexandre Ricard told investors the company does not see the US returning to growth until after 2029. That is not optimism with a delayed timeline. That is capitulation dressed in corporate language. For the medium term, Pernod has trimmed its sales growth guidance to the lower end of a 3% to 6% range through 2029. In other words, it is planning for 3%, not 6%.

Consider the absurdity of the situation. Pernod Ricard sells Martell cognac, Absolut vodka, Chivas Regal, Ballantine's, and a portfolio so deep in prestige brands that it should theoretically be insulated from ordinary economic pressure. Premium spirits are supposed to hold their own when middle-market goods suffer. They are supposed to be the last thing consumers cut. Yet here sits a company that has managed to lose 14% of its US revenue and 19% of its China revenue in a single fiscal year, and is telling investors not to expect recovery for another three-plus years.

The culprits are structural. In the US, weak economic conditions have hit discretionary spending. In China, weak economic conditions have combined with regulatory measures targeting prestige brands. Tourism disruption from Middle East conflict has added noise to the picture, but tourism disruption is not why Martell cannot sell cognac to Americans or Chinese consumers. Demand itself has deteriorated.

This matters because China and the United States are not marginal markets for anyone. They are the world's largest developed and developing economies. They represent the lion's share of global premium goods demand. If luxury spirits cannot move units in both simultaneously, it suggests the weakness is not country-specific or sector-specific. It is demand-specific.

The market understood the implication. Pernod's shares fell 5.18% to €64.10 on the news, their lowest level since late July. The stock sharply underperformed the CAC 40. Investors did not parse this as a temporary setback. They read it as a company managing through a prolonged contraction in its two most important markets, with recovery years away.

Profit from recurring operations did come in slightly better than expected—down 5.2% organically versus a forecast 5.9% decline—which allowed management to claim some operational discipline. But cutting costs while revenue collapses is not a strategy. It is triage.

The real warning here is not about spirits. It is about the consumer. When a company with Pernod's brand portfolio and pricing power cannot grow in America or China, and is openly forecasting stagnation through 2029, it is signalling something uncomfortable about demand conditions. This is not cyclical. The company itself has said so, without using that word.